34-Diener HC, Reches A; Pascual J Et Al.Eletriptan And Cafergot Comparativestudy Group. Efficacy, Tolerability And Safety of Oral Eletriptan and Ergotamine Plus Caffeine (Cafergot) İn The Acute Ttreatment of Migraine; A Multicentre, Randomized, Double-Blind, Placebo Controlled Comparison. European Neurology 2002;47:99-107
35. Ferrari MD, Roon KI, Lipton RB Et Al. Oral Triptans (Serotonin 5HT 1B/1D Agonist) İn Acute Migraine Treatment: A Metaanalysis of 53 Trials. Lancet 2001;358:1668-1675
36-Evers S, Afra J, Freze A, Goadsby P.J.,Linde M, May A. And Sandor P.S. EFNS Guideline on the Drug Treatment of Migraine-Report of An EFNS Task Force. European Journal of Neurology 2006, 13:560-572
37-Ertaş M. Migren. Türkiye Klinikleri Nöroloji Dergisi: Başağrıları Özel Sayısı Editör: Vural O. 2003; 1(2):116-123
38- Mathew N.T. Migrende Önleyici Tedavi, Bölüm 4. Mathew N.T. Ve Evans R.W., Başağrısı El Kitabı. (Lippincott Williams & Wilkins, Philedelphia USA, 2.Baskı, 2005) Türkçe Editörler: Ertaş M. Ve Ertaş N.K. Sigma Yay. 2005;88-112.
39-Ablad B, Dahlof C. Migraine and -Blockade: Modulation of Sympathetic Neuromodulation. Cephalalgia 1986;6:7-13.
40-Diamond S, Medina JL. Double Blind Study of Propranolol for Migraine Prophylaxis. Headache. 1976;16:24-27.
41-Nadelmann JW, Stevens J and Saper JR. Propranolol in the Prophylaxis of Migraine. Headache. 1986;26:175-182.
53



63. SAYFAYA BENZER SAYFALAR

Migrenli hastalarda Rho-kinaz ROCK2 gen polimorfizminin yeri - Sayfa 81
68 88. Bigal ME, Bordini CA, Tepper SJ et al. İntravenouse Dipyrone in the Acute Treatment of Migraine Without Aura and Migraine With Aura:A Randomized, Double-Blind, Placebo Controlled Study. Headache. 2002;42:862-71. 89. Diener HC,Reches A, Pascual J et al. Eletriptan and Cafergot Comparative Study Group Efficacy, Tolerability and Safety of Oral Eletriptan And Ergotamine Lus Cafeine (Cafergot)...
Kronik migren hastalarında venlafaksin ve topiramat tedavisinin karşılaştırılması - Sayfa 73
69. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004; 24: 2-7. 70. Johnson RT, Griffin JW, McArthur JC. Trust BT. Current Therapy in Neurologic Disease. Bakar M (Çeviren) s. 67-70, Ankara, Güneş Tıp Kitabevleri, 2007. 71. US Headache Consortium. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of a acu...

63. SAYFADAKI ANAHTAR KELIMELER

headache
migraine
cephalalgia
treatment
placebo
study


63. SAYFA ICERIGI

34-Diener HC, Reches A; Pascual J Et Al.Eletriptan And Cafergot Comparativestudy Group. Efficacy, Tolerability And Safety of Oral Eletriptan and Ergotamine Plus Caffeine (Cafergot) İn The Acute Ttreatment of Migraine; A Multicentre, Randomized, Double-Blind, Placebo Controlled Comparison. European Neurology 2002;47:99-107
35. Ferrari MD, Roon KI, Lipton RB Et Al. Oral Triptans (Serotonin 5HT 1B/1D Agonist) İn Acute Migraine Treatment: A Metaanalysis of 53 Trials. Lancet 2001;358:1668-1675
36-Evers S, Afra J, Freze A, Goadsby P.J.,Linde M, May A. And Sandor P.S. EFNS Guideline on the Drug Treatment of Migraine-Report of An EFNS Task Force. European Journal of Neurology 2006, 13:560-572
37-Ertaş M. Migren. Türkiye Klinikleri Nöroloji Dergisi: Başağrıları Özel Sayısı Editör: Vural O. 2003; 1(2):116-123
38- Mathew N.T. Migrende Önleyici Tedavi, Bölüm 4. Mathew N.T. Ve Evans R.W., Başağrısı El Kitabı. (Lippincott Williams & Wilkins, Philedelphia USA, 2.Baskı, 2005) Türkçe Editörler: Ertaş M. Ve Ertaş N.K. Sigma Yay. 2005;88-112.
39-Ablad B, Dahlof C. Migraine and -Blockade: Modulation of Sympathetic Neuromodulation. Cephalalgia 1986;6:7-13.
40-Diamond S, Medina JL. Double Blind Study of Propranolol for Migraine Prophylaxis. Headache. 1976;16:24-27.
41-Nadelmann JW, Stevens J and Saper JR. Propranolol in the Prophylaxis of Migraine. Headache. 1986;26:175-182.
53

İlgili Kaynaklar







single.php